Hainan Shuangcheng Pharmaceut (002693) — Tangible Net Worth Ratio
Hainan Shuangcheng Pharmaceut (002693) has a Tangible Net Worth Ratio of 54.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥191.57 Million) from net assets (CN¥419.93 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Hainan Shuangcheng Pharmaceut shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hainan Shuangcheng Pharmaceut Tangible Net Worth Ratio (2009–2025)
This chart shows how Hainan Shuangcheng Pharmaceut's Tangible Net Worth Ratio has changed across 17 annual periods from 2009 to 2025. As of March 2026, the ratio stands at 54.4%, reflecting net assets of CN¥419.93 Million with intangible assets of CN¥191.57 Million CNY. Also explore 002693 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hainan Shuangcheng Pharmaceut (2009–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hainan Shuangcheng Pharmaceut from 2009 to 2025, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Hainan Shuangcheng Pharmaceut.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.0% | CN¥420.53 Million | CN¥189.34 Million | CN¥825.78 Million | ▼ -2.5 pp |
| 2024 | 57.5% | CN¥411.61 Million | CN¥175.02 Million | CN¥783.87 Million | ▼ -9.3 pp |
| 2023 | 66.8% | CN¥517.65 Million | CN¥171.78 Million | CN¥803.25 Million | ▼ -4.8 pp |
| 2022 | 71.6% | CN¥580.94 Million | CN¥164.91 Million | CN¥911.02 Million | ▼ -0.7 pp |
| 2021 | 72.3% | CN¥566.75 Million | CN¥156.92 Million | CN¥854.56 Million | ▼ -5.2 pp |
| 2020 | 77.5% | CN¥598.31 Million | CN¥134.38 Million | CN¥907.68 Million | ▼ -5.5 pp |
| 2019 | 83.0% | CN¥678.26 Million | CN¥115.22 Million | CN¥950.98 Million | ▼ -2.6 pp |
| 2018 | 85.6% | CN¥669.69 Million | CN¥96.48 Million | CN¥1.12 Billion | ▼ -1.1 pp |
| 2017 | 86.7% | CN¥761.71 Million | CN¥101.15 Million | CN¥1.38 Billion | ▲ +5.9 pp |
| 2016 | 80.9% | CN¥553.13 Million | CN¥105.85 Million | CN¥1.17 Billion | ▼ -4.7 pp |
| 2015 | 85.5% | CN¥927.61 Million | CN¥134.20 Million | CN¥1.55 Billion | ▼ -9.1 pp |
| 2014 | 94.6% | CN¥893.55 Million | CN¥48.17 Million | CN¥943.54 Million | ▼ -1.5 pp |
| 2013 | 96.1% | CN¥870.62 Million | CN¥33.54 Million | CN¥917.04 Million | ▲ +0.1 pp |
| 2012 | 96.1% | CN¥845.85 Million | CN¥33.26 Million | CN¥886.65 Million | ▲ +4.0 pp |
| 2011 | 92.0% | CN¥228.23 Million | CN¥18.22 Million | CN¥248.06 Million | ▲ +2.4 pp |
| 2010 | 89.6% | CN¥157.82 Million | CN¥16.42 Million | CN¥252.73 Million | ▲ +5.1 pp |
| 2009 | 84.5% | CN¥77.95 Million | CN¥12.06 Million | CN¥97.85 Million | — |